about
S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domainsBergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic miceTheories of schizophrenia: a genetic-inflammatory-vascular synthesisBiomarkers for sporadic Creutzfeldt-Jakob diseaseThe Impact of Different Environmental Conditions on Cognitive Function: A Focused ReviewPhosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueSeasonal changes in patterns of gene expression in avian song control brain regionsCommunity structure analysis of transcriptional networks reveals distinct molecular pathways for early- and late-onset temporal lobe epilepsy with childhood febrile seizuresBlood biomarkers for brain injury: What are we measuring?Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingBiochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseThe design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegenerationGlial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.A Promising Approach to Integrally Evaluate the Disease Outcome of Cerebral Ischemic Rats Based on Multiple-Biomarker Crosstalk.Is peripheral immunity regulated by blood-brain barrier permeability changes?Blueprint of an ancestral neurosensory organ revealed in glial networks in human dental pulp.Regulation of S100B in white adipose tissue by obesity in mice.S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin ResistancePerinatal S100B Protein Assessment in Human Unconventional Biological Fluids: A Minireview and New PerspectivesAdipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue.Plasma levels of S100B in preeclampsia and association with possible central nervous system effects.Transgenic rat model of Huntington's disease: a histopathological study and correlations with neurodegenerative process in the brain of HD patients.Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.Responses of glial cells to stress and glucocorticoidsA theoretical molecular network for dyslexia: integrating available genetic findings.Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke.Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study.Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.Resveratrol prevents ammonia toxicity in astroglial cellsWhat makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Molecular determinants of S100B oligomer formationTherapeutic potential of fluoxetine in neurological disorders.Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptorSystemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.Electroacupuncture-like stimulation at the Baihui (GV20) and Dazhui (GV14) acupoints protects rats against subacute-phase cerebral ischemia-reperfusion injuries by reducing S100B-mediated neurotoxicityGlial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapyA novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.Serum S100B Protein Levels in Patients with Panic Disorder: Effect of Treatment with Selective Serotonine Reuptake Inhibitors.
P2860
Q24338574-AD1B3D2A-30D6-4F23-A0E5-CAF726DC1476Q24622447-55B1EBBC-690C-4E33-BF2C-280D8F6F8A74Q24800460-E8F099F6-A533-4E66-BB46-20A1132D9003Q26739995-0B4F4522-E0F6-4D72-8A2C-DCA78FD18B3DQ26771510-E2F92110-AC13-4910-8F84-21F856A02093Q26771954-253A4808-7898-462D-BEEA-E8B34009ACCDQ26827833-8853FF2D-E2B8-4657-863B-D3CEC652B390Q27304709-BCDCCB95-38A5-4F27-A85B-E08E3DA43139Q27305647-C85FE0B0-74F2-499B-B173-4B520D51D4C0Q28067275-FA523BC9-61BA-4E28-953D-2C2F40477934Q28477836-665905EC-F10F-45FB-90B9-B2BA5A310481Q28542628-77B68ACD-0103-468A-B37A-BD226C64A912Q30460371-484A7392-AD21-4E16-ACF5-615A61608D2EQ30620210-67444EEC-96AB-4CDE-95E4-F84D25FA516AQ33775847-1E7177D8-77CB-4BF5-ACD3-11333C56CBA2Q33838466-1E68FEA2-68D2-495A-9992-88826B785812Q33935131-6BE98418-57C9-48DC-BA56-C296681D3573Q33946405-CDD21320-7EB3-48DA-8329-D65DB21AE6FEQ33984573-ECF785F7-01D2-4C2A-831F-0338712396EBQ33993909-5257AFDC-EBD4-4493-871E-31F52290D513Q34002819-11552DAE-0AD6-40AD-B241-C4B2A804907AQ34016354-AA3E2E0E-BB2B-4256-B29C-06B1219746E2Q34064518-2B7A3C2F-915C-45D5-8F55-8A3EEFB50B56Q34066247-E3EED0B0-925A-4E30-A9CB-F1BC98541219Q34076038-D80AC02B-1C1B-4CD5-A15C-C9EFDD0335D3Q34144455-E2D6E08D-9F23-4B83-BBA6-D44DAAE59B47Q34321555-9EDD42D1-1C15-43A9-879F-4F9FE3A2690FQ34391480-7D759147-155F-42BB-B92E-8ABF8ABC22DCQ34416323-4B5FB4E6-AF08-4E20-A9F1-9BA059578387Q34533205-F046AF62-5179-419C-9A30-D42BED998978Q34619162-4717CF99-37B2-4D8F-950B-64BDAF07EDFCQ34698701-2B09AB42-03DE-45BF-9BA9-A77DAB0455CBQ34778793-8631B759-CAA8-4564-B7F9-7A0E61BC7E6BQ35002122-6C0F32A1-C6A8-47C3-9D3D-FDAD0919F1D8Q35094550-36F1F616-1651-44EC-BAD4-BB34C48E657DQ35110705-54F2C01A-0181-4A76-A7A4-1D8EDF644740Q35120153-9074A51F-A825-43A3-B7D7-D513B02C722BQ35126073-5DA522AB-553A-48DA-8569-98C41170C24AQ35142344-17700ABF-B1DF-4AAB-B567-76047E6F182AQ35330647-967583BA-20C5-4754-9EAA-DA446DB6A0E7
P2860
description
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im April 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/04/15)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/04/15)
@nl
наукова стаття, опублікована у квітні 2003
@uk
مقالة علمية نشرت في 15-4-2003 حول موضوع: دماغ
@ar
name
S100B in brain damage and neurodegeneration
@ast
S100B in brain damage and neurodegeneration
@en
S100B in brain damage and neurodegeneration
@nl
type
label
S100B in brain damage and neurodegeneration
@ast
S100B in brain damage and neurodegeneration
@en
S100B in brain damage and neurodegeneration
@nl
prefLabel
S100B in brain damage and neurodegeneration
@ast
S100B in brain damage and neurodegeneration
@en
S100B in brain damage and neurodegeneration
@nl
P2093
P2860
P3181
P356
P1476
S100B in brain damage and neurodegeneration
@en
P2093
Jochen H. M. Prehn
Marion Peters
Matthias Rothermundt
Volker Arolt
P2860
P304
P3181
P356
10.1002/JEMT.10303
P577
2003-04-15T00:00:00Z